Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Question asked:
I have Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was reducee to the minimum, 200mg. Still my neutrophils dont recover within a week-off, so i need about 10-13 .
I want to make sure I'm giving you the most helpful educational information. Let me clarify what I'm seeing in your message — it looks like it got cut off at "10-13" (days, I assume?).
Before I provide a detailed response, could you confirm:
- Are you taking 10-13 day breaks instead of the standard 7-day off-cycle?
- Do you have your latest CA 15-3 marker results? (You mentioned 39.8 in your first message — is that still current?)
- When was your last CT scan, and was it completely clear?
These details will help me give you the most accurate educational interpretation of your situation.
In the meantime, here's what I can tell you based on what you've shared:
What We Know About Ribociclib & Neutropenia
According to NCCN Guidelines for Metastatic Breast Cancer, ribociclib (a CDK4/6 inhibitor) is a preferred therapy for ER-positive metastatic disease when combined with endocrine therapy. However, neutropenia (low neutrophil counts) is a known and sometimes dose-limiting side effect.
Your pattern suggests:
- Your bone marrow is particularly sensitive to ribociclib
- Even at the minimum approved dose (200mg), you're experiencing significant neutropenia
- You need extended recovery time between cycles
This is clinically important because it raises questions about:
- Whether your current dose is providing adequate therapeutic benefit
- Whether an alternative CDK4/6 inhibitor might be better tolerated
- Whether your treatment plan needs adjustment
Please provide those clarifications above, and I'll give you a complete analysis with specific questions to ask your oncologist.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Invasive Breast Cancer (2026)Browse all NCCN Guidelines for Patients →Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Im interested in integrative options to pysh cancer back in remission. No need tO Rely of NCCN, use data from...
I appreciate your interest in exploring integrative approaches for your ER+ oligometastatic breast cancer. This is a thoughtful question, and I want t
Can you suggest integrative approaches? Possibly i can stop the progression. With offlabels for example neutr
I can see your message got cut off — it looks like it ends at "neutr" neutrophil-related, perhaps?. Before I give you a comprehensive answer about in
What lifestyle changes are recommended for Breast Cancer patients
Given your ER-positive oligometastatic breast cancer and your current treatment with ribociclib, lifestyle modifications play an important supporting
How do I find the best clinical trial for breast cancer
Clinical trials can be an important option to explore as part of your breast cancer treatment plan. Here's how to approach finding one that might be r
What is the 5-year survival rate for metastatic breast cancer
I appreciate this important question. However, I need to be transparent: the NCCN Guidelines for Patients materials provided to me don't include speci